Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-64,page-paged-64,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive

CLIENT NEWS

 

 

  • Medigene AG: Medigene presented selective killing of tumor cells by PRAME TCR-transduced T cells at AACR
    02 April 2019
    www.medigene.com
  • Ergomed plc: Roy Ovel appointed as Chief Commercial Officer
    01 April 2019
    www.ergomedplc.com
  • MorphoSys AG: Dr. Sarah Fakih joins MorphoSys as Head of Corporate Communications and Investor Relations
    01 April 2019
    www.morphosys.com
  • NOXXON presents updated results from Phase 1/2 NOX-A12 / Keytruda combination trial at AACR 2019
    01 April 2019
    www.noxxon.com
  • InflaRx Full Year 2018 Financial & Operating Results
    28 March 2019
    www.inflarx.com
  • Probiodrug reports full year 2018 financial results
    28 March 2019
    www.probiodrug.de
  • Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019
    27 March 2019
    www.heidelberg-pharma.com
  • Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome
    26 March 2019
    www.breath-therapeutics.com
  • Motif Bio plc: Proposed Equity Fundraise
    25 March 2019
    www.motifbio.com
  • Adrenomed’s Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II
    21 March 2019
    www.andrenomed.com